company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2493000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,882000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-11117000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,49052000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5044000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5044000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1039000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12164000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-358000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12845000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12845000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,193000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60118000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1334000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,79534000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28241000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28241000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2586000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,633000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5558000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7760000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27224000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27224000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,517000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10493000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,10000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11020000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11020000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,202000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,135000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,337000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,337000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,265000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15602000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13434000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39898000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2560000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,719000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9184000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1354000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-47157000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-47157000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,90000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,87000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,87000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,213000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,17750000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17662000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,35625000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,35625000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-346000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 20:35:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11791000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22908000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22908000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2576000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,236000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,824000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3873000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23145000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23145000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,162000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-19000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,143000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,143000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,246000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-88000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,166000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,324000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,324000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1544000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21134000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22736000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22736000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2558000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,248000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,765000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-121000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19286000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19286000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,105000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,105000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,105000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,264000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,336000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,336000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-888000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19733000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23682000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2433000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,232000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2821000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2768000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20964000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20964000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,108000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,275000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,77000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-260000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20469000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,9492000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2405000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,261000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-263000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4778000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28952000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28952000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,274000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-50000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,224000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,224000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,288000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,16463000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41283000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58034000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58034000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,577000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:10:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29883000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22099000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22099000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2319000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1537000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8962000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3748000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5533000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5533000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-636000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-274000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,87000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-823000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-823000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22873000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-288000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86329000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63168000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63168000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-516000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,56296000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15521000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15521000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2336000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,202000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15237000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2777000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-523000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-523000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-399000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-357000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-344000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23045000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22701000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22701000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,540000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21963000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1995000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1017000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-38596000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34488000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24410000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24410000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1035000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,745000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3587000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3587000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,23217000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-1000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,561000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1313000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25090000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25090000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-30000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4237000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,7670000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18876000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1950000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,133000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1785000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3216000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18224000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18224000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1266000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-52000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1318000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1318000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-372000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,450000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,78000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,78000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-377000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:15:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19841000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,40100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1927000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,129000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2444000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-895000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,43705000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,43705000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1884000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,32000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,309000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1543000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1543000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-410000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1561000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1151000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1151000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-658000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42655000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17200000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1886000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,145000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2292000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14676000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1799000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1799000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1450000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,28000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,210000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1212000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1212000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-434000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,674000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,240000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,240000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,971000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1798000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1970000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,198000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12604000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,95615000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,86928000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,86928000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,4600000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,9164000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-906000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12858000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12858000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1216000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,630000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1664000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3510000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3510000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,65000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,103361000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6954000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25255000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1992000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,215000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3156000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,776000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19116000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19116000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2469000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,45000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,209000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2215000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2215000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2927000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-466000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2461000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2461000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,264000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:13:13+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18606000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7480000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7480000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2209000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-29937000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13813000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33919000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33919000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1950000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33277000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31329000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31329000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1331000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-507000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,824000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,824000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-708000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2474000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10672000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10672000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2233000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,139000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12659000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4998000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25957000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25957000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2025000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16276000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14251000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14251000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,634000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-534000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-864000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12470000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32061000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32061000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2221000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,146000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-850000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8138000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22406000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22406000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2461000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2461000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2461000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,333000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-550000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-217000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-217000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-35000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25119000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6778000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24295000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2425000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,61000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5041000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23017000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23017000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1069000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1069000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1069000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,101979000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-570000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101409000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101409000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,449000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,77772000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26807000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2524000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,97000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4114000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3891000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23963000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23963000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-55000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,684000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-614000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,70000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,70000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,368000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24280000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26418000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26418000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2452000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,91000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4855000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7239000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26259000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26259000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9031000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2232000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6799000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6799000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,271000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-645000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-374000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-374000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1989000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35421000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,2728000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33187000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-1971000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-113000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1843000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9673000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-1119000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24874000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,9681000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,664000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10345000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-9873000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,472000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,694000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4321000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5015000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5015000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-725000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-4984000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25096000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6562000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21548000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21548000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2356000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,101000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2674000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1162000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17579000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17579000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-247000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,135000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-112000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-112000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,127000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-687000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-560000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-560000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1600000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:18:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16651000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2353000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,71000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4245000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4327000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16187000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16187000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-130000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,26000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-104000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-104000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,103000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-734000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-631000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-631000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-625000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17547000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12479000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12479000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2296000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3140000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12691000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19700000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-267000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,625000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-659000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-301000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-301000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,58000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-768000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-710000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-710000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,354000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20357000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,38314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-10596000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48910000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-2011000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-70000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2286000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-66942000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17827000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,9817000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8010000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-170000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,168000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-236000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-233000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,320000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,82000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5168000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5570000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5570000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1623000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4296000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6303000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22497000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,54000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22551000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1110000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1771000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7301000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12335000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-3922000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16257000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,60000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,45000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5267000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-816000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4451000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4451000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,578000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:06:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11183000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23616000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,147000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23763000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1080000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1717000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4089000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25021000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-907000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25928000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-29000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,76229000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-868000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,75361000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,75361000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1846000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51234000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32664000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,2606000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35270000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1044000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13866000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1117000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19209000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,900000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18309000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,789000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,789000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,789000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,166833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-904000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,165929000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,165929000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-434000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,147975000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13955000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,315000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14270000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1044000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2097000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3868000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7227000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,1079000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6148000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-406000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-112615000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-113108000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-71000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-113179000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,476000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6106000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6582000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6582000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1990000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-114735000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5967000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31963000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-830000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31133000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,949000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-144000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4033000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2884000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29179000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-601000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29780000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-325000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25477000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25005000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-799000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,2990000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2191000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,385256000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,960000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,386216000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,384296000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:19:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,356707000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31833000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,953000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,37000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8945000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1566000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38222000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,499000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37723000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-203000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21895000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21696000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,415000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22111000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,737000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14875000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34314000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,961000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,319000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2673000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-394000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30755000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-268000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31023000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38133000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37990000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37990000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1470000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1056000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,414000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,414000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7381000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,68711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,68711000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,896000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-766000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4201000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-106765000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33723000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,37000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33686000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-124000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-338960000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25531000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-313565000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-313565000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,552000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7032000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7584000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7584000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-339667000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5696000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,620134000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,620134000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,764000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1125000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13024000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,104853000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,737650000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,737650000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1095000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-249525000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76088000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-174532000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-174532000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3364000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-760000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2604000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2604000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 17:12:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,565722000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61403000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,791000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2258000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13428000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5670000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55112000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55112000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-839000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-660206000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,183696000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-477349000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,997000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-476352000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4722000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-810000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3912000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3912000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-527552000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72865000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72865000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,794000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1550000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13345000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7860000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52416000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52416000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-999000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-338913000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,359657000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19745000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19745000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4602000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-846000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3756000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3756000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28915000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88311000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,884000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-605000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17106000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9498000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-61428000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-61428000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1886000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-220576000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,356652000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,134190000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,134190000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,459000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5698000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6157000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6157000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78919000.0
Arena Pharmaceuticals Inc,ARNA,,0001080709,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4787000.0
